收费全文 | 3515篇 |
免费 | 225篇 |
国内免费 | 40篇 |
耳鼻咽喉 | 11篇 |
儿科学 | 99篇 |
妇产科学 | 74篇 |
基础医学 | 483篇 |
口腔科学 | 33篇 |
临床医学 | 303篇 |
内科学 | 967篇 |
皮肤病学 | 64篇 |
神经病学 | 558篇 |
特种医学 | 80篇 |
外科学 | 280篇 |
综合类 | 9篇 |
预防医学 | 157篇 |
眼科学 | 68篇 |
药学 | 233篇 |
中国医学 | 4篇 |
肿瘤学 | 357篇 |
2024年 | 12篇 |
2023年 | 61篇 |
2022年 | 125篇 |
2021年 | 189篇 |
2020年 | 126篇 |
2019年 | 142篇 |
2018年 | 150篇 |
2017年 | 95篇 |
2016年 | 122篇 |
2015年 | 156篇 |
2014年 | 160篇 |
2013年 | 189篇 |
2012年 | 313篇 |
2011年 | 327篇 |
2010年 | 174篇 |
2009年 | 163篇 |
2008年 | 237篇 |
2007年 | 178篇 |
2006年 | 187篇 |
2005年 | 148篇 |
2004年 | 136篇 |
2003年 | 127篇 |
2002年 | 102篇 |
2001年 | 29篇 |
2000年 | 19篇 |
1999年 | 22篇 |
1998年 | 18篇 |
1997年 | 8篇 |
1996年 | 6篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1993年 | 9篇 |
1992年 | 9篇 |
1991年 | 1篇 |
1990年 | 3篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 4篇 |
1986年 | 3篇 |
1985年 | 2篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1966年 | 1篇 |
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
The liver contribution to the biological network underlying physical frailty in aging is underestimated. How best to measure this contribution magnitude and impact on health risk trajectories in frail individuals is not yet entirely clear. We analyzed the association of a novel liver frailty phenotype with the risk of death in older participants of the Salus in Apulia Study cohort. Clinical and physical examination, routine biomarkers, medical history, and anthropometry were analyzed in 1929 older adults (65?+). Physical frailty was classified by Cardiovascular Health Study criteria, and liver fibrosis risk by fibrosis-4 (FIB-4). The liver frailty phenotype was defined as physical frailty plus high-risk liver fibrosis (score?>?2.67). Physical frailty, high-risk liver fibrosis, and liver frailty subjects were compared to subjects without these conditions (non-frail). Proportional Cox regression tested the adjusted association between liver frailty and all-cause mortality for each category. The liver frailty prevalence was relatively low (3.8%), but higher in men (58.1%). Compared to non-frail older subjects, liver frailty subjects were significantly older (effect size (ES)???1.11, 95% confidence interval (CI)???1.35 to???0.87), with a lower education (ES 0.48, 95%CI 0.24 to 0.71) and higher multimorbidity (ES 15.81, 95%CI 4.20 to 27.41). Cox multivariate analyses showed a two-fold increased risk of overall mortality (hazard ratio 2.09, 95%CI 1.16–3.74) even after the adjustment for age, sex, education, and alcohol consumption. The liver frailty phenotype runs twice the risk of overall mortality compared with the non-frail population. This clinical tool, validated in a Southern Italian population, is based on simple sets of measures that can conveniently be assessed also in the primary care setting.
相似文献Areas covered: The authors provide the reader with an overview of the different positions of regulatory authorities on the interchangeability and automatic substitution of biosimilars and reference products. Presently, the FDA allows automatic substitution without prescriber intervention if the biosimilar is interchangeable with reference products, while the European Medicines Agency delegate to each single EU member state.
Expert opinion: Different approaches in defining interchangeability and automatic substitution call for harmonization to increase confidence of healthcare professionals and patients about the clinical impact of switching. Networks of electronic healthcare records and administrative databases, potentially linkable to clinical charts and registries may rapidly assess frequency and benefit-risk profile of different switching patterns in routine care at different levels, thus integrating and strengthening pre-marketing evidence. 相似文献